Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.
| Revenue (TTM) | $2.99B |
| Gross Profit (TTM) | $1.70B |
| EBITDA | $226.00M |
| Operating Margin | -11.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $10.64 |
| Book Value | — |
| Price-to-Book | 0.98 |
| Price-to-Sales (TTM) | 1.11 |
| EV/Revenue | 1.134 |
| EV/EBITDA | 75.34 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 15.00% |
| Shares Outstanding | $280.82M |
| Float | $28.00M |
| % Insiders | 90.51% |
| % Institutions | 1.97% |